These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38895818)

  • 21. DHCR24 reverses Alzheimer's disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xFAD mice.
    Zhang WB; Huang Y; Guo XR; Zhang MQ; Yuan XS; Zu HB
    Acta Neuropathol Commun; 2023 Jun; 11(1):102. PubMed ID: 37344916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ERβ and ApoE isoforms interact to regulate BDNF-5-HT
    Chhibber A; Zhao L
    Alzheimers Res Ther; 2017 Sep; 9(1):79. PubMed ID: 28934977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of early Alzheimer's disease-like molecular alterations in a mouse model expressing human ApoE4.
    Rai A; Ojiakor OA; Rylett RJ
    J Neurochem; 2023 Aug; 166(3):572-587. PubMed ID: 37415276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
    Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
    Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
    Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
    J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of chronic stress on anxiety-like behavior and cognitive function in different human GFAP-ApoE transgenic adult male mice.
    Meng FT; Zhao J; Fang H; Liu YJ
    Stress; 2015; 18(4):419-26. PubMed ID: 25938810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
    Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
    Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
    Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
    J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer's Disease.
    Faraji P; Kühn H; Ahmadian S
    J Mol Neurosci; 2024 Jul; 74(3):62. PubMed ID: 38958788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOE and Alzheimer's disease: Pathologic clues from transgenic Drosophila melanogaster.
    Haddadi M; Haghi M; Rezaei N; Kiani Z; Akkülah T; Celik A
    Arch Gerontol Geriatr; 2024 Aug; 123():105420. PubMed ID: 38537387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
    Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
    J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy.
    Xiong M; Wang C; Gratuze M; Saadi F; Bao X; Bosch ME; Lee C; Jiang H; Serrano JR; Gonzales ER; Kipnis M; Holtzman DM
    Mol Neurodegener; 2023 Mar; 18(1):17. PubMed ID: 36922879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice.
    Thomas R; Zuchowska P; Morris AW; Marottoli FM; Sunny S; Deaton R; Gann PH; Tai LM
    Acta Neuropathol Commun; 2016 Oct; 4(1):111. PubMed ID: 27788676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mTOR inhibition enhances synaptic and mitochondrial function in Alzheimer's disease in an APOE genotype-dependent manner.
    Sanganahalli BG; Mihailovic JM; Vekaria HJ; Coman D; Yackzan AT; Flemister A; Aware C; Wenger K; Hubbard WB; Sullivan PG; Hyder F; Lin AL
    J Cereb Blood Flow Metab; 2024 Oct; 44(10):1745-1758. PubMed ID: 38879800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.
    Huang Y
    Biochem Soc Trans; 2011 Aug; 39(4):924-32. PubMed ID: 21787325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
    Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
    Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer's disease.
    Liu CC; Wang N; Chen Y; Inoue Y; Shue F; Ren Y; Wang M; Qiao W; Ikezu TC; Li Z; Zhao J; Martens Y; Doss SV; Rosenberg CL; Jeevaratnam S; Jia L; Raulin AC; Qi F; Zhu Y; Alnobani A; Knight J; Chen Y; Linares C; Kurti A; Fryer JD; Zhang B; Wu LJ; Kim BYS; Bu G
    Nat Immunol; 2023 Nov; 24(11):1854-1866. PubMed ID: 37857825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice.
    Engstrom AK; Snyder JM; Maeda N; Xia Z
    Mol Neurodegener; 2017 Feb; 12(1):14. PubMed ID: 28173832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease.
    Li Y; Macyczko JR; Liu CC; Bu G
    Neurobiol Aging; 2022 Jul; 115():20-28. PubMed ID: 35453035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.